SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 121 filers reported holding SERES THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,339 | -48.9% | 29,134 | +2.8% | 0.00% | 0.0% |
| Q2 2023 | $135,701 | -17.1% | 28,330 | -1.9% | 0.00% | 0.0% |
| Q1 2023 | $163,750 | +4.4% | 28,880 | +3.1% | 0.00% | -50.0% |
| Q4 2022 | $156,845 | -9.3% | 28,008 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $173,000 | +188.3% | 26,952 | +54.7% | 0.00% | +100.0% |
| Q2 2022 | $60,000 | -54.9% | 17,423 | -6.4% | 0.00% | 0.0% |
| Q1 2022 | $133,000 | -13.6% | 18,621 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $154,000 | +18.5% | 18,514 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $130,000 | -70.7% | 18,729 | +0.7% | 0.00% | -75.0% |
| Q2 2021 | $444,000 | +15.9% | 18,603 | +0.0% | 0.00% | +33.3% |
| Q1 2021 | $383,000 | -12.2% | 18,594 | +4.4% | 0.00% | -25.0% |
| Q4 2020 | $436,000 | – | 17,807 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |